High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva

This publication has 8 references indexed in Scilit:

• Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects
  Antimicrobial Agents and Chemotherapy, 1997
• Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
  Nature Medicine, 1996
• A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection
  New England Journal of Medicine, 1995
• A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
  New England Journal of Medicine, 1995
• Quantification of the anti‐HIV drug saquinavir by high‐speed on‐line high‐performance liquid chromatography/tandem mass spectrometry
  Journal of Mass Spectrometry, 1995
• ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
  Proceedings of the National Academy of Sciences, 1995
• Calibration and validation of linearity in chromatographic biopharmaceutical analysis
  Journal of Pharmaceutical and Biomedical Analysis, 1991